Hemophilia Center of Western Pennsylvania

Recent papers from Hemophilia Center of Western Pennsylvania

1. Risk of Postpartum Hemorrhage in Women With Von Willebrand Disease: A Real‐World Data AnalysisHaemophilia · 2026
2. The Essential Role of Psychosocial Care in Comprehensive Haemophilia Treatment: Global Perspectives From Haemophilia Treatment Centres and National Member OrganizationsHaemophilia · 2026
3. Evaluating Costs and Efficacy of rFVIII Prophylaxis Using Matching-Adjusted Indirect Comparisons in Hemophilia ATH Open · 2026
4. Lack of Inhibitor Development in Previously Treated People With Haemophilia Switching Factor Products—Final Results of Athn 2: Factor Switching StudyHaemophilia · 2026
5. Inherited Platelet Disorders During Pregnancy and Delivery: Overview of Management Strategies and Emerging Therapeutic ConsiderationsHematology Reports · 2026
6. Hemophilia Severity and Its Association With Mental Health and Health‐Related Quality of Life—Results From a Cross‐Sectional Multicenter StudyHaemophilia · 2026
7. Digital cognitive behavioral therapy versus Education for chronic pain in adults with sickle cell disease: 12-month randomized trial resultsAnnals of Behavioral Medicine · 2026
8. Risk of postpartum hemorrhage in women with von willebrand disease by treatment type: An analysis of real-world dataBlood · 2025
9. Toward Artificial Intelligence in Oncology and Cardiology: A Narrative Review of Systems, Challenges, and OpportunitiesJournal of Clinical Medicine · 2025
10. Impact of Tranexamic Acid on Postpartum Hemorrhage in Type 1 von Willebrand Disease Treated with Recombinant VWFBlood Advances · 2025
11. Heavy Menstrual Bleeding and Hormonal Therapy in Women with Type 1 von Willebrand Disease Enrolled on the Zimmerman ProgramClinical and Applied Thrombosis/Hemostasis · 2025
12. The Iron Ladies: Prevalence and Risk Factors of Iron Deficiency in Females With Bleeding DisordersHaemophilia · 2025
13. Long-term safety and efficacy of fitusiran prophylaxis, and perioperative management, in people with hemophilia A or BBlood Advances · 2024
14. Glycoprotein 1bM Assay and Von Willebrand Disease: A Change in DiagnosisBlood · 2024
15. Inhibitor development upon switching from plasma-derived to recombinant factor VIII in previously untreated patients with severe hemophilia A: the PUP-SWITCH studyResearch and Practice in Thrombosis and Haemostasis · 2024
16. Predictors of liver disease outcomes in individuals with hemophilia and HCV infectionBlood Advances · 2024
17. Optimizing liver health before and after gene therapy for hemophilia ABlood Advances · 2024
18. Observational cohort study of long‐term outcomes of liver transplantation in haemophiliaHaemophilia · 2023
19. Adherence to Clotting Factor Treatment and Association with Bleeding and Health-Related Quality of Life in Persons with HemophiliaBlood · 2023
20. Efficacy of adjusted weight-based dosing of desmopressin (1-deamino-8-d-arginine vasopressin in type 1 von Willebrand diseaseBlood Coagulation & Fibrinolysis · 2023